Skip to main content
Top
Published in: Digestive Diseases and Sciences 12/2016

01-12-2016 | Original Article

Predictive Factors for Pain After Endoscopic Resection of Gastric Tumors

Authors: Seung Young Kim, Sung Woo Jung, Jung Wan Choe, Jong Jin Hyun, Young Kul Jung, Ja Seol Koo, Hyung Joon Yim, Sang Woo Lee

Published in: Digestive Diseases and Sciences | Issue 12/2016

Login to get access

Abstract

Background

Abdominal pain is a common complaint following endoscopic resection (ER).

Aims

To investigate the predictive factors for abdominal pain after ER.

Methods

Patients who were scheduled to undergo endoscopic mucosal resection or endoscopic submucosal dissection for the treatment of gastric adenoma or cancer were prospectively enrolled. Pain scores were checked every 6 h after ER and whenever patients complained of pain by using a 0–10 pain scale. If the pain score exceeded 5, 25 mg of intravenous (IV) pethidine was administered.

Results

Among 156 patients who underwent ER, 66 (42.3 %) received IV pethidine due to moderate/severe abdominal pain. Both the number of patients complaining of abdominal pain and the pain scores decreased with time following the procedure, with only a few patients complaining of mild abdominal pain 2 days after ER. Multivariate analysis showed that female sex [odds ratio (OR) 2.88; confidence interval (CI) 1.31–6.33], tumor location in the lower third of the stomach (OR 5.46; CI 2.31–12.92), and procedures time more than 60 min (OR 2.96; CI 1.26–6.98) were significant predictive factors for developing pain after ER.

Conclusions

Female sex, tumor location in the lower third of the stomach, and longer procedure time were significantly associated with pain after ER. Close monitoring and active management of pain is recommended for patients who have these risk factors. With these efforts, the majority of patients could experience pain relief within 2 days after the procedure.
Literature
2.
3.
go back to reference Jensen MP, Chen C, Brugger AM. Interpretation of visual analog scale ratings and change scores: a reanalysis of two clinical trials of postoperative pain. J Pain. 2003;4:407–414.CrossRefPubMed Jensen MP, Chen C, Brugger AM. Interpretation of visual analog scale ratings and change scores: a reanalysis of two clinical trials of postoperative pain. J Pain. 2003;4:407–414.CrossRefPubMed
4.
go back to reference Serlin RC, Mendoza TR, Nakamura Y, Edwards KR, Cleeland CS. When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain. 1995;61:277–284.CrossRefPubMed Serlin RC, Mendoza TR, Nakamura Y, Edwards KR, Cleeland CS. When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain. 1995;61:277–284.CrossRefPubMed
5.
go back to reference Lee HW, Lee H, Chung H, et al. The efficacy of single-dose postoperative intravenous dexamethasone for pain relief after endoscopic submucosal dissection for gastric neoplasm. Surg Endosc. 2014;28:2334–2341.CrossRefPubMed Lee HW, Lee H, Chung H, et al. The efficacy of single-dose postoperative intravenous dexamethasone for pain relief after endoscopic submucosal dissection for gastric neoplasm. Surg Endosc. 2014;28:2334–2341.CrossRefPubMed
7.
8.
go back to reference Ohta T, Ishihara R, Uedo N, et al. Factors predicting perforation during endoscopic submucosal dissection for gastric cancer. Gastrointest Endosc. 2012;75:1159–1165.CrossRefPubMed Ohta T, Ishihara R, Uedo N, et al. Factors predicting perforation during endoscopic submucosal dissection for gastric cancer. Gastrointest Endosc. 2012;75:1159–1165.CrossRefPubMed
9.
go back to reference Toyonaga T, Man-i M, East JE, et al. 1,635 Endoscopic submucosal dissection cases in the esophagus, stomach, and colorectum: complication rates and long-term outcomes. Surg Endosc. 2013;27:1000–1008.CrossRefPubMed Toyonaga T, Man-i M, East JE, et al. 1,635 Endoscopic submucosal dissection cases in the esophagus, stomach, and colorectum: complication rates and long-term outcomes. Surg Endosc. 2013;27:1000–1008.CrossRefPubMed
10.
go back to reference Green CR, Hart-Johnson T, Loeffler DR. Cancer-related chronic pain: examining quality of life in diverse cancer survivors. Cancer. 2011;117:1994–2003.CrossRefPubMed Green CR, Hart-Johnson T, Loeffler DR. Cancer-related chronic pain: examining quality of life in diverse cancer survivors. Cancer. 2011;117:1994–2003.CrossRefPubMed
11.
go back to reference Turk DC. Clinical effectiveness and cost-effectiveness of treatments for patients with chronic pain. Clin J Pain. 2002;18:355–365.CrossRefPubMed Turk DC. Clinical effectiveness and cost-effectiveness of treatments for patients with chronic pain. Clin J Pain. 2002;18:355–365.CrossRefPubMed
12.
go back to reference Stewart WF, Ricci JA, Chee E, Morganstein D, Lipton R. Lost productive time and cost due to common pain conditions in the US workforce. JAMA. 2003;290:2443–2454.CrossRefPubMed Stewart WF, Ricci JA, Chee E, Morganstein D, Lipton R. Lost productive time and cost due to common pain conditions in the US workforce. JAMA. 2003;290:2443–2454.CrossRefPubMed
13.
go back to reference Choi HS, Kim KO, Chun HJ, et al. The efficacy of transdermal fentanyl for pain relief after endoscopic submucosal dissection: a prospective, randomised controlled trial. Dig Liver Dis. 2012;44:925–929.CrossRefPubMed Choi HS, Kim KO, Chun HJ, et al. The efficacy of transdermal fentanyl for pain relief after endoscopic submucosal dissection: a prospective, randomised controlled trial. Dig Liver Dis. 2012;44:925–929.CrossRefPubMed
14.
go back to reference Lee H, Cheoi KS, Chung H, et al. Clinical features and predictive factors of coagulation syndrome after endoscopic submucosal dissection for early gastric neoplasm. Gastric Cancer. 2012;15:83–90.CrossRefPubMed Lee H, Cheoi KS, Chung H, et al. Clinical features and predictive factors of coagulation syndrome after endoscopic submucosal dissection for early gastric neoplasm. Gastric Cancer. 2012;15:83–90.CrossRefPubMed
15.
go back to reference Cha JM, Lim KS, Lee SH, et al. Clinical outcomes and risk factors of post-polypectomy coagulation syndrome: a multicenter, retrospective, case-control study. Endoscopy. 2013;45:202–207.CrossRefPubMed Cha JM, Lim KS, Lee SH, et al. Clinical outcomes and risk factors of post-polypectomy coagulation syndrome: a multicenter, retrospective, case-control study. Endoscopy. 2013;45:202–207.CrossRefPubMed
16.
go back to reference Onogi F, Araki H, Ibuka T, et al. “Transmural air leak”: a computed tomographic finding following endoscopic submucosal dissection of gastric tumors. Endoscopy. 2010;42:441–447.CrossRefPubMed Onogi F, Araki H, Ibuka T, et al. “Transmural air leak”: a computed tomographic finding following endoscopic submucosal dissection of gastric tumors. Endoscopy. 2010;42:441–447.CrossRefPubMed
17.
go back to reference Kim B, Lee H, Chung H, et al. The efficacy of topical bupivacaine and triamcinolone acetonide injection in the relief of pain after endoscopic submucosal dissection for gastric neoplasia: a randomized double-blind, placebo-controlled trial. Surg Endosc. 2015;29:714–722.CrossRefPubMed Kim B, Lee H, Chung H, et al. The efficacy of topical bupivacaine and triamcinolone acetonide injection in the relief of pain after endoscopic submucosal dissection for gastric neoplasia: a randomized double-blind, placebo-controlled trial. Surg Endosc. 2015;29:714–722.CrossRefPubMed
18.
go back to reference Uehara R, Isomoto H, Minami H, et al. Characteristics of gastrointestinal symptoms and function following endoscopic submucosal dissection and treatment of the gastrointestinal symptoms using rikkunshito. Exp Ther Med. 2013;6:1083–1088.PubMedPubMedCentral Uehara R, Isomoto H, Minami H, et al. Characteristics of gastrointestinal symptoms and function following endoscopic submucosal dissection and treatment of the gastrointestinal symptoms using rikkunshito. Exp Ther Med. 2013;6:1083–1088.PubMedPubMedCentral
19.
go back to reference Meleine M, Matricon J. Gender-related differences in irritable bowel syndrome: potential mechanisms of sex hormones. World J Gastroenterol. 2014;20:6725–6743.CrossRefPubMedPubMedCentral Meleine M, Matricon J. Gender-related differences in irritable bowel syndrome: potential mechanisms of sex hormones. World J Gastroenterol. 2014;20:6725–6743.CrossRefPubMedPubMedCentral
20.
go back to reference Berkley KJ. Sex differences in pain. Behav Brain Sci. 1997;20:371–380.PubMed Berkley KJ. Sex differences in pain. Behav Brain Sci. 1997;20:371–380.PubMed
21.
go back to reference Kellow JE, Borody TJ, Phillips SF, Tucker RL, Haddad AC. Human interdigestive motility: variations in patterns from esophagus to colon. Gastroenterology. 1986;91:386–395.CrossRefPubMed Kellow JE, Borody TJ, Phillips SF, Tucker RL, Haddad AC. Human interdigestive motility: variations in patterns from esophagus to colon. Gastroenterology. 1986;91:386–395.CrossRefPubMed
22.
go back to reference Parkman HP, Jones MP. Tests of gastric neuromuscular function. Gastroenterology. 2009;136:1526–1543.CrossRefPubMed Parkman HP, Jones MP. Tests of gastric neuromuscular function. Gastroenterology. 2009;136:1526–1543.CrossRefPubMed
Metadata
Title
Predictive Factors for Pain After Endoscopic Resection of Gastric Tumors
Authors
Seung Young Kim
Sung Woo Jung
Jung Wan Choe
Jong Jin Hyun
Young Kul Jung
Ja Seol Koo
Hyung Joon Yim
Sang Woo Lee
Publication date
01-12-2016
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 12/2016
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-016-4325-9

Other articles of this Issue 12/2016

Digestive Diseases and Sciences 12/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.